Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients

Abstract

We describe the pharmacokinetics of subcutaneous and transdermal fentanyl in one patient cohort and report several findings that are relevant for clinical practice. Further research is warranted to study the optimal scheme for rotations from the subcutaneous to the transdermal route.